Axcelis Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Axcelis Technologies 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ACLS
Axcelis Technologies, Inc. engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. Its ion implantation systems product line includes high and medium current, and energy implanters.
CEORussell J. Low
CEORussell J. Low
Employees1,524
Employees1,524
HeadquartersBeverly, Massachusetts
HeadquartersBeverly, Massachusetts
Founded1978
Founded1978
Employees1,524
Employees1,524
ACLS Key Statistics
Market cap2.76B
Market cap2.76B
Price-Earnings ratio20.81
Price-Earnings ratio20.81
Dividend yield—
Dividend yield—
Average volume498.48K
Average volume498.48K
High today$89.74
High today$89.74
Low today$85.76
Low today$85.76
Open price$86.99
Open price$86.99
Volume466.94K
Volume466.94K
52 Week high$102.93
52 Week high$102.93
52 Week low$40.40
52 Week low$40.40
Stock Snapshot
As of today, Axcelis Technologies(ACLS) shares are valued at $89.10. The company's market cap stands at 2.76B, with a P/E ratio of 20.81.
During the trading session on 2025-12-05, Axcelis Technologies(ACLS) shares reached a daily high of $89.74 and a low of $85.76. At a current price of $89.10, the stock is +3.9% higher than the low and still -0.7% under the high.
Trading activity shows a volume of 466.94K, compared to an average daily volume of 498.48K.
Over the past 52 weeks, Axcelis Technologies(ACLS) stock has traded between a high of $102.93 and a low of $40.40.
Over the past 52 weeks, Axcelis Technologies(ACLS) stock has traded between a high of $102.93 and a low of $40.40.
Analyst ratings
50%
of 8 ratingsBuy
37.5%
Hold
50%
Sell
12.5%
People also own
Based on the portfolios of people who own ACLS. This list is generated using Robinhood data, and it’s not a recommendation.